A phenanthronitrile organic luminescent compound and its preparation method and application

By introducing electron donor groups on the phenanthrit structure, D-A or D-π-A type TADF molecules are formed, the stacking problem caused by excessive molecular conjugation is solved, high luminescence quantum yield and wavelength regulation are achieved, and significantly improved Properties of TADF materials.

CN116003340BActive Publication Date: 2024-11-19GUANGDONG UNIV OF TECH
View PDF 5 Cites 0 Cited by

Patent Information

Application Number
CN202211685689.7
Authority / Receiving Office
CN · China
Patent Type
Patents(China)
Current Assignee / Owner
Filing Date
2022-12-27
Publication Date
2024-11-19
Estimated Expiration
2042-12-27

AI Technical Summary

Technical Problem

When designing thermally activated delayed fluorescence (TADF) materials, excessive molecular conjugation leads to easy accumulation of compounds, exciton non-radiative transitions, and reduces luminescent quantum yields.

Method used

By introducing electron donor groups on the phenanthrit structure, the D-A or D-π-A type structure is formed, the singlet-tritile energy level difference of molecular, the steric resistance is increased, and the electron donor group is adjusted by adjusting the electron donor group. The type of luminescence wavelength is regulated.

Benefits of technology

High luminescence quantum yield and wavelength regulation were achieved, significantly reducing the quenching of compound concentrations. The luminescence quantum yield only decreased by 5.1% to 13% at high concentrations, and the luminescence wavelength of the molecules was successfully regulated.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN116003340B_ABST
    Figure CN116003340B_ABST
Patent Text Reader

Abstract

The invention discloses a phenanthronitrile compound and its preparation method and application, and relates to the field of organic light-emitting. Based on the electron-withdrawing effect of cyano, the present invention constructs a phenanthronitrile mother core with electron-withdrawing ability, and then introduces an electron donor group D on the phenanthronitrile mother core, and provides a phenanthronitrile compound with D-A or D-π-A type structure and excellent thermally activated delayed fluorescence (TADF) performance brought about thereby, and the conjugated system of the compound is small, and the donor space steric hindrance is also large, which solves the concentration quenching problem caused by conjugated stacking common in D-A type TADF compounds; at the same time, the present invention realizes the regulation of the luminous wavelength of the compound by changing the type of D, and has good application prospects in the field of organic light-emitting.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The present invention relates to the field of organic luminescent materials, and more specifically, to a phenanthronitrile compound and a preparation method and application thereof. Background Art

[0002] Organic light-emitting materials used as organic light-emitting diodes (OLED) are widely used in high-definition display devices, white light illumination, and flexible wearable devices. Due to the significant advantages of organic light-emitting materials such as flexibility, high color saturation and illumination, ultra-high resolution, and ultra-fast response speed, they have great application potential in flat panel displays, smart phones, and solid-state lighting, and have attracted widespread attention from academia and industry around the world.

[0003] Thermally activated delayed fluorescence (TADF) materials are a type of organic light-emitting material. This type of material generally has a small singlet-triplet energy level difference. Triplet excitons can be transformed into singlet excitons through reverse intersystem crossing. Singlet excitons return to the ground state through radiation transition, which can make the material emit light. In theory, TADF materials can achieve 100% internal quantum efficiency, so TADF materials are popular materials in the preparation of OLED devices.

[0004] At present, a widely used idea in designing TADF molecules is to construct an electron donor-electron acceptor (DA) structure with a charge transfer state. However, when constructing DA or D-π-A type TADF compounds, there is often a problem of excessive molecular conjugation, which makes the compound prone to concentration quenching, that is, when the concentration of the compound increases, the planar conjugated molecules will accumulate, so the excitons are prone to non-radiative transitions and annihilation between molecules, which reduces the system's luminescence quantum yield.

[0005] The phenanthrene structure is a commonly used fragment in DA-type TADF organic light-emitting molecules. However, most of the current molecules use phenanthrene to expand the conjugation of the system and lack direct modification of phenanthrene. Therefore, there are common problems such as large molecular receptor conjugation, severe stacking, and luminescence quenching. Summary of the invention

[0006] The present invention is based on the fact that the phenanthronitrile structure can be used as an electron acceptor A, and the electron donor D is directly introduced into the phenanthronitrile structure to form a DA or D-π-A type TADF molecule with a small conjugated system. The thermally activated delayed fluorescence performance is excellent, and the steric hindrance of the electron donor D is relatively large, which overcomes the problem of compound concentration quenching caused by the stacking of the electron acceptor conjugated plane that is common in DA type TADF molecules. At the same time, the present invention realizes the regulation of the luminescent wavelength of the compound by changing the type of D.

[0007] Another object of the present invention is to provide a method for preparing phenanthronitrile compounds.

[0008] Another object of the present invention is to provide an application of phenanthronitrile compounds.

[0009] Another object of the present invention is to provide an organic light emitting device.

[0010] In order to solve the above technical problems, the technical solution adopted by the present invention is:

[0011] A phenanthronitrile compound having a molecular structure as shown in formula (I) or (II):

[0012]

[0013] Wherein the two R groups are independently selected from -H, -CN or Any one or more of, and at least one R is -CN; D1 and D2 are electron donor groups, each independently selected from the following structural formula:

[0014]

[0015] One or more of, wherein R1 is selected from any one of -H, -t-Bu.

[0016] The present invention is based on a phenanthronitrile system as an electron acceptor (A), and by introducing an electron donating group (D) therein, a molecule having a DA or D-π-A structure is formed. The molecule having a DA or D-π-A structure can form a twisted spatial structure through the steric hindrance effect between the groups, and the overlap between the HOMO energy level and the LUMO energy level respectively localized on the electron donating group and the electron acceptor group will be reduced, thereby reducing the molecular singlet-triplet energy level difference, promoting the reverse intersystem crossing process of the exciton inside the molecule, and making the compound have the performance of thermally activated delayed fluorescence (TADF) and a theoretical luminescence quantum yield of up to 100%.

[0017] By directly introducing the electron donor group D into the phenanthronitrile structure, the DA or D-π-A type TADF molecular conjugated system provided by the present invention is small enough, which solves the problem that such molecules tend to form planar stacking when the concentration increases due to the large planar conjugated system, thereby causing exciton annihilation and reduced quantum luminescence yield.

[0018] At the same time, the present invention adjusts the type of electron donor group D, that is, adjusts the electron donating ability and steric hindrance effect of D, thereby adjusting the electrostatic interaction between DA in the molecular structure and the internal torsion angle of the molecule, thereby achieving the regulation of the singlet-triplet energy level difference of the molecule, thereby achieving the purpose of regulating the luminescence wavelength of the molecule.

[0019] Preferably, the electron donor groups D1 and D2 in the phenanthronitrile compounds provided by the present invention are independently selected from the following structural formulas:

[0020] One or more of, wherein R1 is selected from any one of -H, -t-Bu.

[0021] The above-mentioned phenoxazine group, triphenylamine group and spirofluorene acridinium group are all electron donor groups with large steric hindrance. At the same time, the conjugated area of ​​the phenanthrene nucleus is small, which leads to the difficulty of the molecules to form a stack of conjugated planes when the molecular concentration in the system increases, and then, it is difficult for the excitons to undergo non-radiative transitions between molecules. Therefore, the DA-type TADF molecules constructed by using the above-mentioned groups and the phenanthrene nucleus have a smaller reduction in the luminescence quantum yield when the molecular concentration in the system increases, and the concentration quenching effect of the DA-type TADF molecules is better improved. At the same time, there is a strong electrostatic interaction between the above-mentioned groups and the phenanthrene nitrile parent nucleus, and the singlet-triplet energy level difference of the excitons is low, which makes it easier to undergo reverse intersystem crossing. Therefore, the compounds constructed by the above-mentioned groups and the phenanthrene nucleus have a higher luminescence quantum yield. At the same time, the above-mentioned three groups have different electron donating abilities. By connecting them to the phenanthrene nitrile parent nucleus, DA-type TADF compounds with different emission wavelengths can be obtained.

[0022] Preferably, the phenanthronitrile compound provided by the present invention has a molecular structure as shown in one of the following formulas:

[0023]

[0024]

[0025] In the formula, R1 is selected from any one of -H and -t-Bu.

[0026] Based on the electrostatic interaction between DA and the steric hindrance effect of the electron donor D, the compound having a structure represented by one of the above molecular formulas has a higher luminescence quantum yield and a lower concentration quenching effect.

[0027] More preferably, the phenanthronitrile compound provided by the present invention has a molecular structure as shown in one of the following formulas:

[0028]

[0029]

[0030] The above compounds are respectively composed of phenoxazine groups, triphenylamine groups and spirofluorene acridinium groups with greater steric hindrance connected to phenanthrene cores, and have a better improvement effect on the concentration quenching effect of DA-type TADF molecules.

[0031] The present invention protects a method for preparing the compound of the above formula (I), comprising the following steps:

[0032] S1. Using copper and cuprous iodide to catalyze the self-coupling of 2-bromo-4-fluorotoluene under nitrogen protection to obtain 5,5'-difluoro-2,2'-dimethyl-1,1'-biphenyl;

[0033] S2. The 5,5'-difluoro-2,2'-dimethyl-1,1'-biphenyl prepared in S1 is mixed with bromosuccinimide and reacted to prepare 2,2'-bis(dibromomethyl)-5,5'-difluoro-1,1'-biphenyl;

[0034] S3. Mix and react the 2,2'-bis(dibromomethyl)-5,5'-difluoro-1,1'-biphenyl obtained in S2 with potassium tert-butoxide to obtain intermediate α1

[0035] S4. Dissolve the intermediate α1 prepared in S3 and cuprous cyanide in N-methylpyrrolidone to prepare intermediate β1 under nitrogen protection.

[0036] S5. The intermediate β1 prepared in S4 is dissolved together with the alkaline salt and the donor group in an organic solvent, and heated to prepare a phenanthronitrile compound having a molecular structure as shown in formula (I).

[0037] Preferably, in step S1, the molar ratio of 2-bromo-4-fluorotoluene, copper and cuprous iodide is 1:(0.1-0.5):(0.1-0.5).

[0038] In this step of the reaction, copper and cuprous iodide play a catalytic role. Since the effect of the catalyst is to increase the reaction rate and the increase in the reaction rate has an upper limit, the amount of the catalyst does not need to be too high. After comprehensively considering factors such as cost and catalytic effect, the ratio of the catalyst to the reactant is limited to the above range.

[0039] Preferably, the reaction temperature in step S1 is 160-190° C., and the reaction time is 24-36 hours.

[0040] By limiting the reaction temperature and time within the above ranges, the yield of the reaction product can be increased.

[0041] Preferably, the molar ratio of 5,5'-difluoro-2,2'-dimethyl-1,1'-biphenyl to bromosuccinimide in step S2 is 1:(4.5-10).

[0042] Preferably, the reaction conditions in step S2 are: temperature of 80-85° C., light illumination, and reaction time of 36-48 h.

[0043] Step S2 is a bromination reaction on the alkyl group. The role of bromosuccinimide (NBS) is to provide bromine free radicals, and the generation of bromine free radicals requires light to trigger the homolysis of carbon-bromine bonds. Since the free radicals themselves are relatively active and easily consumed, the amount of NBS required is relatively large; limiting the molar ratio of the reactants and the reaction conditions within the above range can increase the yield of the reaction product.

[0044] Preferably, in step S3, the molar ratio of 2,2'-bis(dibromomethyl)-5,5'-difluoro-1,1'-biphenyl to potassium tert-butoxide is 1:(3.2-4.5).

[0045] Preferably, the reaction temperature of step S3 is -5 to 0°C, and the reaction time is 1 to 2 hours.

[0046] Step S3 is a ring-forming reaction, and the role of potassium tert-butoxide is to remove the hydrogen atoms connected to the carbon atoms substituted with dibromo. However, due to the large steric hindrance provided by biphenyl, the efficiency of dehydrogenation is low; limiting the molar ratio of the reactants and the reaction conditions within the above range can increase the yield of the reaction product.

[0047] Preferably, in step S4, the molar ratio of the intermediate α1 to cuprous cyanide is 1:(3-4).

[0048] Preferably, in step S4, the reaction temperature is 160-180° C., and the reaction time is 24-48 h.

[0049] Preferably, in step S5, the alkaline salt is selected from any one of sodium carbonate, potassium carbonate, cesium carbonate, potassium tert-butoxide or sodium hydride.

[0050] Step S5 is a nucleophilic substitution reaction. The presence of alkaline salt can provide an alkaline environment for the system and promote the departure of hydrogen.

[0051] Preferably, in step S5, the molar ratio of the intermediate α1 to the basic salt is 1:(2-2.5).

[0052] Preferably, in step S5, the organic solvent for the reaction is one of toluene, DMF and DMSO.

[0053] Preferably, in step S5, the reaction conditions are to react in an inert gas atmosphere at 100° C. to 160° C. for 12 to 24 hours.

[0054] In order to keep the reaction system of step S5 dry, an inert gas is introduced into the system, and the reaction temperature and time are limited to the above ranges, which can increase the yield of the product.

[0055] The reaction conditions such as the type of alkaline salt, the molar ratio of reactants and the solvent are limited within the above ranges in order to increase the yield of the reaction product.

[0056] The present invention protects another method for preparing the compound of formula (I), comprising the following steps:

[0057] S1. Mixing 2-(4-bromophenyl)acetonitrile, iodine and a base, and reacting them to obtain 2,3-bis(4-bromophenyl)fumaronitrile;

[0058] S2. Mix the 2,3-bis(4-bromophenyl)fumaronitrile obtained in step S1 with iodine and react under light to obtain

[0059] S3. The 3,6-dibromophenyl-9,10-dinitrile, donor group, alkaline salt and phosphine palladium catalyst prepared in step S2 are mixed and heated to prepare a phenanthronitrile compound having a molecular structure as shown in formula (I).

[0060] Preferably, the reaction conditions in step S1 are to react in an inert gas atmosphere at -5 to -78°C for 12 to 24 hours.

[0061] Preferably, the base used in the reaction in step S1 is selected from any one or more of sodium hydroxide, sodium methoxide and sodium ethoxide.

[0062] The reason for providing low temperature reaction conditions to the reactants in step S1 is that the bases added in this step are all strong bases, which are prone to violent reactions with the solution system, but the above-mentioned strong bases can make the self-coupling reaction of 2-(4-bromophenyl)acetonitrile have a higher yield.

[0063] Preferably, the organic solvent used in the reaction in step S1 is selected from any one or more of diethyl ether, carbon tetrachloride, methanol and ethanol.

[0064] Preferably, in step S2, the light source used for illumination is a 150W 395nm ultraviolet lamp, and the reaction time is 12 to 24 hours.

[0065] Preferably, the molar ratio of 2,3-bis(4-bromophenyl)fumaronitrile to iodine in step S2 is 1:(0.001-0.01).

[0066] Preferably, the molar ratio of 3,6-dibromophenyl-9,10-dicarbonitrile, donor group, basic salt and coupling agent containing phosphine or palladium in step S3 is 1:(2.2-2.5):(2.2-5):(0.01-0.4).

[0067] Preferably, the coupling agent containing phosphine or palladium in step S3 is one or more of tetrakistriphenylphosphine palladium, trisdibenzylideneacetone dipalladium and tri-tert-butylphosphine tetrafluoroborate.

[0068] Preferably, the alkaline salt in step S3 is selected from any one or more of sodium carbonate, potassium carbonate, cesium carbonate, potassium tert-butoxide and sodium hydride.

[0069] Preferably, the solvent in step S3 is a mixed solvent consisting of toluene, ethanol and water.

[0070] More preferably, the solvent in step S3 is a mixed solvent consisting of toluene, ethanol and water in a volume ratio of 6:2:1.

[0071] The reactants in step S3 include 3,6-dibromophenyl-9,10-dinitrile, a donor group and an alkaline salt, which have both water-soluble and oil-soluble components. When the solvent is a single polar or non-polar solvent, the reactants of different properties will be divided into two phases, which are not easy to react with each other. Therefore, the present invention adopts a mixed solvent composed of toluene, ethanol and water to dissolve the reactants and form a homogeneous emulsion, thereby improving the yield of the reaction product. When the volume ratio of toluene, ethanol and water is 6:2:1, the yield of the reaction is the highest.

[0072] Preferably, in step S3, the reaction conditions are: reacting at 80-110° C. in an inert gas atmosphere for 12-24 hours.

[0073] The reaction conditions such as the type of alkaline salt, the molar ratio of reactants and the solvent are limited within the above ranges in order to increase the yield of the reaction product.

[0074] The present invention protects a method for preparing the compound of formula (II), comprising the following steps:

[0075] S1. Using copper and cuprous iodide to catalyze the self-coupling of 1-bromo-4-fluoro-2-toluene under nitrogen protection to prepare 4,4'-difluoro-2,2'-dimethyl-1,1'-biphenyl;

[0076] S2. The 4,4'-difluoro-2,2'-dimethyl-1,1'-biphenyl prepared in S1 is mixed with bromosuccinimide and reacted to prepare 2,2'-bis(dibromomethyl)-4,4'-difluoro-1,1'-biphenyl;

[0077] S3. Mixing and reacting the 2,2'-bis(dibromomethyl)-4,4'-difluoro-1,1'-biphenyl obtained in S2 with potassium tert-butoxide to obtain a 2,7-substituted intermediate α2;

[0078] S4. The intermediate α2 prepared in S3 and cuprous cyanide are dissolved in N-methylpyrrolidone to prepare a 2,7-substituted intermediate β2 under nitrogen protection;

[0079] S5. The intermediate β2 prepared in S4 is dissolved together with the alkaline salt and the donor group in an organic solvent, and heated to prepare a phenanthronitrile compound having a molecular structure as shown in (II).

[0080] The present invention also protects the application of the above-mentioned phenanthronitrile compounds in organic light-emitting devices.

[0081] Preferably, in the application of the above-mentioned phenanthronitrile compounds in an organic light-emitting device, the organic light-emitting device has one or more light-emitting layers, and the light-emitting layers contain at least one or more of the above-mentioned phenanthronitrile compounds.

[0082] Different compounds have different characteristic emission wavelengths, but often the emission wavelength of a single compound is also relatively single; using different compounds in the light-emitting layer material and using multiple light-emitting layers are important means to enable organic electroluminescent devices to achieve full-band luminescence.

[0083] The present invention also protects an organic light-emitting device, in which the light-emitting layer is composed of the above-mentioned phenanthronitrile compound.

[0084] Compared with the prior art, the present invention has the following beneficial effects:

[0085] The phenanthronitrile compound provided by the present invention uses the phenanthronitrile structure as the electron acceptor A, and introduces an electron donor substituent D at the 2, 7 or 3, 6 positions of the phenanthronitrile structure. Due to the DA or D-π-A type structure and the large steric hindrance of D, the large torsion angle between D and A, and the reduced overlap between the HOMO and LUMO of the molecule, the singlet-triplet energy level difference of the molecule is small, the thermally activated delayed fluorescence (TADF) performance is excellent, and the luminescence quantum yield is high; the conjugated system of the compound is small and the steric hindrance of D is large, which also makes the compound less prone to concentration quenching. According to the results of the embodiment of the present invention, when the concentration of the compound in the system increases by 10 times, the degree of decrease in the luminescence quantum yield of the system is only between 5.1% and 13%, that is, the concentration quenching phenomenon is well suppressed; at the same time, the present invention realizes the regulation of the luminescence wavelength of the compound by changing the type of D. According to the results of the embodiment of the present invention, by changing the electron donor group, the present invention increases the luminescence wavelength of the molecule from 531nm to 693nm, and realizes the regulation of the wavelength of the system and long-wave emission. BRIEF DESCRIPTION OF THE DRAWINGS

[0086] Figure 1 This is the hydrogen nuclear magnetic resonance spectrum of compound M1 prepared in Example 1 of the present invention.

[0087] Figure 2 This is the mass spectrum of compound M1 prepared in Example 1 of the present invention.

[0088] Figure 3This is the hydrogen nuclear magnetic resonance spectrum of compound M2 prepared in Example 2 of the present invention.

[0089] Figure 4 This is the mass spectrum of compound M2 prepared in Example 2 of the present invention.

[0090] Figure 5 This is the hydrogen nuclear magnetic resonance spectrum of compound M3 prepared in Example 3 of the present invention.

[0091] Figure 6 This is the mass spectrum of compound M3 prepared in Example 3 of the present invention.

[0092] Figure 7 This is the hydrogen nuclear magnetic resonance spectrum of compound M4 prepared in Example 4 of the present invention.

[0093] Figure 8 This is the mass spectrum of compound M4 prepared in Example 4 of the present invention.

[0094] Fig. 9 The compounds M1, M2, M3 and M4 in the examples of the present invention are 1.0×10 -5 Fluorescence emission spectrum of M in toluene solution.

[0095] Fig.10 This is a single crystal stacking diagram of M1 in Example 1 of the present invention.

[0096] Fig.11 Schematic diagram of the device structure of the organic light-emitting device in Example 6 of the present invention and the energy levels and chemical structure of the device materials.

[0097] Fig.12 This is a normalized EL spectrum diagram of the organic light-emitting device in Example 6 of the present invention.

[0098] Fig.13 This is a power efficiency-brightness diagram of the organic light-emitting device in Example 6 of the present invention.

[0099] Fig.14 This is a brightness-EQE characteristic diagram of the organic light-emitting device in Example 6 of the present invention. DETAILED DESCRIPTION

[0100] The present invention is further described below in conjunction with specific embodiments, but the embodiments do not limit the present invention in any form. Unless otherwise specified, the raw materials and reagents used in the embodiments of the present invention are conventionally purchased raw materials and reagents.

[0101] Example 1

[0102] This embodiment provides a phenanthronitrile compound M1, M1 having a molecular structure as shown in the above general formula (I), wherein the two R groups in the formula are both -CN, and D1 and D2 are phenoxazine groups:

[0103]

[0104] The preparation method of the phenanthrene nitrile compound M1 in the above embodiment 1 specifically comprises the following steps:

[0105] S1. Preparation of 5,5'-difluoro-2,2'-dimethyl-1,1'-biphenyl:

[0106] 10g 2-bromo-4-fluorotoluene (52.91mmol), 0.67g copper (10mmol), 2.01g cuprous iodide (10mmol) were added to the flask, heated to 180°C under nitrogen protection, and reacted for 36h. The heating was stopped, cooled to room temperature, 500mL water was added, and dichloromethane was used for extraction. The liquid was separated, and the upper organic phase was taken and pure petroleum ether was passed through a column to obtain 7.8g (yield 67.2%) of colorless aromatic liquid, which was 5,5'-difluoro-2,2'-dimethyl-1,1'-biphenyl.

[0107] S2. Preparation of 2,2'-bis(dibromomethyl)-5,5'-difluoro-1,1'-biphenyl;

[0108] 5,5'-difluoro-2,2'-dimethyl-1,1'-biphenyl (7g, 32.11mmol) and NBS (5eq, 160.55mol) were added to a 250ml two-necked round-bottom flask, and the mixture was evacuated and nitrogen was passed through; carbon tetrachloride (100ml) was added, stirring was started, the temperature was raised to 85°C, and the mixture was reacted for 48 hours under reflux and light conditions. After cooling to room temperature, carbon tetrachloride was removed by rotary evaporation, and pure petroleum ether was used to pass through a column to obtain a yellow mixed solution. Low-boiling substances were removed by rotary evaporation, the mixture was cooled, and the solid was washed with a small amount of petroleum ether to obtain 11.98g of a white solid product (yield 70%), which was 2,2'-bis(dibromomethyl)-5,5'-difluoro-1,1'-biphenyl.

[0109] S3. Preparation of intermediate α1: 9,10-dibromo-3,6-difluorophenanthrene;

[0110] Dissolve 2,2'-bis(dibromomethyl)-5,5'-difluoro-1,1'-biphenyl (10 g, 18.76 mmol) and potassium tert-butoxide (6.78 g, 60.60 mmol) in 150 mL of anhydrous DMF. Stir at 0°C under nitrogen protection and react for 2 hours. After the reaction, add a large amount of water to precipitate the solid, filter and collect 7.94 g of off-white solid (yield 95%), which is the intermediate α1: 9,10-dibromo-3,6-difluorophenanthrene.

[0111] S4. Preparation of intermediate β1: 3,6-difluorophenanthrene-9,10-dicarbonitrile;

[0112] Dissolve the intermediate α1 (5 g, 13.44 mmol) and cuprous cyanide (4.33 g, 48.38 mmol) in 120 mL of N-methylpyrrolidone, protect with nitrogen, stir and heat to 160 ° C for 36 h. After the reaction is completed, cool to room temperature, add a large amount of water to precipitate the solid, filter, extract the solid with dichloromethane, and filter the insoluble impurities. Rotary evaporate, pass the column with a mixed solution of dichloromethane / petroleum ether = 1:2 (V / V), and obtain 0.99 g of 3,6-difluorophenanthrene-9,10-dicarbonitrile solid (yield 28%).

[0113] Preparation of S5.M1:

[0114] The intermediate 3,6-difluorophenanthrene-9,10-dicarbonitrile (0.1 g, 0.38 mmol), phenoxazine (0.17 g, 0.95 mmol) and potassium tert-butoxide (0.11 g, 0.95 mmol) were dissolved in 3 ml of DMF, stirred and heated at 120°C under nitrogen protection for 12 h. After the reaction, the reaction solution was poured into 100 ml of water to precipitate the solid, filtered, and the solid was taken. A mixed solution of dichloromethane: petroleum ether = 1:4 (V / V) was passed through the column to obtain 0.134 g of a red solid (yield 60%), which was M1.

[0115] Figure 1 is the hydrogen nuclear magnetic resonance spectrum of the phenanthrene nitrile compound M1 prepared in Example 1. It can be seen that: 1 H NMR (400MHz, Chloroform-d) δ8.74 (s, 4H), 8.66 (s, 2H), 8.55 (s, 2H), 7.87 (s, 2H), 7.67 (s, 2H), 6.86 (d, J = 1.4 Hz, 4H), 6.74 (s, 32H). The molecular hydrogen spectrum peaks can correspond to the target product one by one, and the quantity is reasonable.

[0116] Figure 2 is the mass spectrum of the phenanthrene nitrile compound M1 prepared from Example 1. Figure 2 It can be seen that the relative molecular mass is 589.89, which is consistent with the relative molecular mass of M1. Combining the above NMR and mass spectrometry results, it can be seen that the product obtained in Example 1 is M1.

[0117] Fig.10 This is the single crystal stacking diagram of the M1 molecule in Example 1. It can be seen from the figure that due to the small conjugated area of ​​the phenanthrene nitrile core and the large steric hindrance provided by the donor distribution on the outside, the molecules can only be arranged "tail to tail" in layers, that is, the substituents at the ends of adjacent molecules are "aligned" with each other. At this time, the planar phenanthrene nuclei at the centers of adjacent molecules are difficult to stack tightly, and the molecular planar stacking is small, which is conducive to alleviating the luminescence quenching caused by molecular stacking.

[0118] Example 2

[0119] This embodiment provides a phenanthronitrile compound M2, M2 having a molecular structure as shown in the above general formula (I), wherein one of the R groups is -CN, and the other R group and D1 and D2 are all phenoxazine groups:

[0120]

[0121] The preparation method of the phenanthrene nitrile compound M2 in the above embodiment 2 specifically comprises the following steps:

[0122] S1 to S3 are the same as in Example 1. The difference from Example 1 is the following steps:

[0123] S4. Preparation of intermediate β1: 10-bromo-3,6-difluorophenanthrene-9-carbonitrile:

[0124] Dissolve the intermediate α1 (5 g, 13.44 mmol) and cuprous cyanide (4.33 g, 48.38 mmol) in 120 mL of N-methylpyrrolidone, protect with nitrogen, stir and heat to 160 ° C for 36 h. After the reaction is completed, cool to room temperature, add a large amount of water to precipitate the solid, filter, extract the solid with dichloromethane, and filter the insoluble impurities. Rotary evaporate, pass through a column with a mixed solution of dichloromethane / petroleum ether = 1:2 (V / V), and obtain 2.1 g of 10-bromo-3,6-difluorophenanthrene-9-carbonitrile solid (yield 49%).

[0125] Preparation of S5.M2:

[0126] The intermediate 10-bromo-3,6-difluorophenanthrene-9-carbonitrile (0.1 g, 0.31 mmol), phenoxazine (0.18 g, 1 mmol) and potassium tert-butoxide (0.11 g, 1 mmol) were dissolved in 3 ml of DMF, stirred and heated at 120°C under nitrogen protection for 12 h. After the reaction, the reaction solution was poured into 100 ml of water, filtered, and the solid was obtained. The mixed solution was passed through a column with dichloromethane: petroleum ether = 1:4 (V / V) to obtain 0.098 g of a red solid (yield 42%).

[0127] Figure 3 This is the hydrogen nuclear magnetic resonance spectrum of the phenanthrene nitrile compound M2 prepared in Example 2. It can be seen that: 1H NMR (400MHz, Chloroform-d) δ8.81-8.70 (dd, J = 6.8, 1.9 Hz, 2H), 8.70-8.63 (d, J = 8.6 Hz, 1H), 8.58-8.52 (d, J = 8.7 Hz, 1H), 7.89-7.81 (dd, J = 8.6, 1.9 Hz, 1H), 7.71-7.64 (dd, J = 8.7, 1.8 Hz, 1H), 6.93-6.51 (m, 18H), 6.05-5.86 (m, 6H). The molecular hydrogen spectrum peaks can correspond to the target product one by one, and the quantity is reasonable.

[0128] Figure 4 The mass spectrum of the phenanthrene nitrile compound M2 prepared in Example 2. Figure 4 It can be seen that the relative molecular mass of the molecule is 747, which is consistent with the relative molecular mass of M2. Combining the above NMR and mass spectrometry results, it can be seen that the product obtained in Example 2 is M2.

[0129] The preparation steps of the phenanthroline compounds of Examples 1 to 2 can be summarized by the following preparation routes:

[0130]

[0131] Example 3

[0132] This embodiment provides a phenanthronitrile compound M3, M3 having a molecular structure as shown in the above general formula (I), wherein the two R groups are -CN, and D1 and D2 are triphenylamine groups:

[0133]

[0134] The preparation method of the phenanthrene nitrile compound M3 in the above-mentioned embodiment 3 specifically comprises the following steps:

[0135] S1. Preparation of 2,3-bis(4-bromophenyl)fumaronitrile

[0136] At -78°C, 2-(4-bromophenyl)acetonitrile (5g, 25.5mmol) and iodine (8.4g, 33.2mol) were added to a 250ml two-necked round-bottom flask, dissolved in 100mL of ether, and evacuated with nitrogen; 3.44g of sodium methoxide (63.75mol) was dissolved in 60mL of methanol, gradually added dropwise to the flask, and stirred at room temperature for 24h. The reaction solution was washed with sodium thiosulfate solution, separated, dried, and recrystallized to obtain 2.01g of 2,3-bis(4-bromophenyl)fumaronitrile (yield 40%).

[0137] S2. Preparation of 3,6-dibromophenyl-9,10-dicarbonitrile

[0138] A catalytic amount of iodine (5 mg, 0.02 mmol) was added to a toluene (200 mL) solution of 2,3-bis(4-bromophenyl)fumaronitrile (2 g, 5.15 mmol). A 150 W high pressure mercury lamp was used to provide illumination conditions for the reaction solution. The reaction was monitored by TLC and the solvent was removed under reduced pressure. The product was purified by silica gel column chromatography using a mixed solution of dichloromethane: petroleum ether = 1:1 (V / V) as an eluent to obtain 3,6-dibromophenyl-9,10-dinitrile 1.5 g (yield 75%).

[0139] Preparation of S3.M3

[0140] In a nitrogen atmosphere, 1 g (2.59 mmol) of 3,6-dibromophenyl-9,10-dicarbonitrile, 1.65 g (5.69 mmol) of 4-triphenylamine borate, 50 mg (0.04 mmol) of tetrakistriphenylphosphine palladium, and 0.73 g (6.88 mmol) of sodium carbonate were dissolved in a mixed solution of toluene / ethanol / water = 6:2:1 (V / V / V). After stirring at 110°C for 12 hours, the solvent was removed by rotary evaporation, and the product M3 was obtained by purification by silica gel column chromatography.

[0141] The above preparation steps can be summarized by the following preparation route:

[0142]

[0143] Figure 5 This is the hydrogen nuclear magnetic resonance spectrum of the phenanthrene nitrile compound M3 prepared in Example 3. It can be seen that: 1 H NMR (400MHz, Chloroform-d) δ8.91 (s, 2H), 8.40 (s, 2H), 8.07 (s, 2H), 7.66 (s, 4H), 7.32 (s, 8H), 7.19 (s, 12H), 7.10 (s, 4H). The molecular hydrogen spectrum peaks can correspond to the target products one by one, and the quantity is reasonable.

[0144] Figure 6 The mass spectrum of the phenanthrene nitrile compound M3 prepared in Example 3. Figure 6 It can be seen that the molecular weight is 715, which is the anion peak of the M3 molecule. Combining the above NMR and mass spectrometry results, it can be seen that the product obtained in Example 3 is M3.

[0145] Example 4

[0146] This embodiment provides a phenanthronitrile compound M4, M4 has a molecular structure as shown in the above general formula (I), wherein the two R groups in the formula are both -CN, and D1 and D2 are both spirofluorene acridinyl groups:

[0147]

[0148] The preparation method of the phenanthrene nitrile compound M4 in the above-mentioned embodiment 4 specifically comprises the following steps:

[0149] S1-S2 are the same as in Example 3. The difference from Example 3 is the following steps:

[0150] S3. Preparation of M4 from intermediates:

[0151] Under nitrogen atmosphere, 1 g (2.59 mmol) 3,6-dibromophenyl-9,10-dicarbonitrile, 1.88 g (5.69 mmol) 10H spiro[acridine-9,9'-fluorene], 50 mg (0.04 mmol) Pd2(dba)3, 0.73 g (7.60 mmol) sodium tert-butoxide, 60 mg (0.21 mmol) P(t-Bu)3 / HBF4 were dissolved in 100 mL toluene. After stirring at 110°C for 12 hours, the solvent was dried and purified by silica gel column chromatography to obtain product M4 (40%).

[0152] The preparation steps of S3 can be summarized as follows:

[0153]

[0154] Figure 7 This is the hydrogen nuclear magnetic resonance spectrum of the phenanthronitrile compound M4 prepared in Example 4. It can be seen that: 1H NMR (400MHz, Chloroform-d) δ7.94 (s, 1H), 7.68 (s, 3H), 7.33 (s, 11H), 6.92 (d, J = 48.9 Hz, 23H). The molecular hydrogen spectrum peaks can correspond to the target product one by one, and the quantity is reasonable.

[0155] Figure 8 The mass spectrum of the phenanthronitrile compound M4 prepared in Example 4. Figure 8 It can be seen that the molecular weight is 887, which is the anion peak of the M4 molecule. Combining the above NMR and mass spectrometry results, it can be seen that the product obtained in Example 4 is M4.

[0156] Example 5

[0157] This embodiment provides a phenanthronitrile compound M5, M5 having a molecular structure as shown in the above general formula (I), wherein one R group is -CN, the other R group is -H, and D1 and D2 are phenothiazine groups:

[0158]

[0159] The preparation method of the phenanthrene nitrile compound M5 in the above-mentioned embodiment 5 is different from that in the embodiment 1 in that:

[0160] S1. The reactants are 2-bromo-4-fluoro-1-toluene, copper and cuprous iodide.

[0161] S2. The reactants are 5,5'-difluoro-2,2'-dimethyl-1,1'-biphenyl and NBS.

[0162] S3. The reactants are 2-(bromomethyl)-2'-(dibromomethyl)-5,5'-difluoro-1,1'-biphenyl and potassium tert-butoxide.

[0163] S4. The reactants are intermediate α and cuprous cyanide.

[0164] S5. The reactants are intermediate β, phenothiazine and potassium tert-butoxide.

[0165] Example 6

[0166] An organic light-emitting device, wherein the light-emitting layer material is prepared by vacuum evaporation of M1 provided in Example 1 or M2 provided in Example 2.

[0167] Fig.11 Schematic diagram of the device structure of the organic light-emitting device in Example 6 of the present invention and the energy levels and chemical structure of the device materials.

[0168] Fig.12 is a normalized EL spectrum diagram of the organic light emitting device in Example 6 of the present invention. Fig.12 It can be seen that the organic light-emitting device prepared using M1 is a red light-emitting device with a light-emitting wavelength of 624 nm, and the organic light-emitting device prepared using M2 is an orange light-emitting device with a light-emitting wavelength of 586 nm.

[0169] Fig.13 This is a power efficiency-brightness diagram of the organic light-emitting device in Example 6 of the present invention.

[0170] Fig.14 This is a brightness-EQE characteristic diagram of the organic light-emitting device in Example 6 of the present invention.

[0171] Since the compound provided in the embodiment has TADF properties, the EQE, or external quantum efficiency, of the device reaches 6.6% and 8.4% respectively when the light-emitting layer materials are M1 and M2, exceeding the 5% theoretical limit of traditional fluorescence.

[0172] Example 7

[0173] This embodiment provides a phenanthronitrile compound M6, M6 has a molecular structure as shown in the above general formula (I), and the specific molecular structure is as follows:

[0174]

[0175] The preparation method of the phenanthronitrile compound M6 in the above-mentioned embodiment 7 is different from that in the embodiment 1 in that:

[0176] S5. The reactants are intermediate β2, 9,10-dihydro-9,9-dimethylacridine and potassium tert-butoxide.

[0177] Example 8

[0178] This embodiment provides a phenanthronitrile compound M7, M7 has a molecular structure as shown in the above general formula (I), and the specific molecular structure is as follows:

[0179]

[0180] The preparation method of the phenanthrene nitrile compound M7 in the above-mentioned embodiment 8 is different from that in the embodiment 1 in that:

[0181] S5. The reactants are intermediate β2, carbazole and potassium tert-butoxide.

[0182] Example 9

[0183] This embodiment provides a phenanthronitrile compound M8, M8 has a molecular structure as shown in the above general formula (I), and the specific molecular structure is as follows:

[0184]

[0185] The preparation method of the phenanthrene nitrile compound M8 in the above-mentioned embodiment 9 is different from that in the embodiment 3 in that:

[0186] S1. The reactants are 2-(4-bromophenyl)acetonitrile, sodium methoxide and iodine.

[0187] S2. The reactants are 2,3-bis(4-bromophenyl)fumaronitrile and iodine.

[0188] S3. The reactants are 3,6-dibromophenanthrene-9,10-dicarbonitrile, 4-(9H-9-carbazole)phenylboronic acid, sodium carbonate, and tetrakistriphenylphosphine palladium.

[0189] Example 10

[0190] This embodiment provides a phenanthronitrile compound M9, M9 has a molecular structure as shown in the above general formula (II), and the specific molecular structure is as follows:

[0191]

[0192] The method for preparing the phenanthrene nitrile compound M9 in Example 10 is different from that in Example 1 in that:

[0193] S1. The reactants are 1-bromo-4-fluoro-2-methylbenzene, copper and cuprous iodide.

[0194] S2. The reactants are 4,4'-difluoro-2,2'-dimethyl-1,1'-biphenyl and NBS.

[0195] S3. The reactants are 2,2'-bis(dibromomethyl)-4,4'-difluoro-1,1'-biphenyl and potassium tert-butoxide.

[0196] S4. The reactants are intermediate α2 and cuprous cyanide.

[0197] S5. The reactants are intermediate β2, phenoxazine and potassium tert-butoxide.

[0198] Embodiment 11

[0199] This embodiment provides a phenanthronitrile compound M10, M10 has a molecular structure as shown in the above general formula (II), and the specific molecular structure is as follows:

[0200]

[0201] The preparation method of the phenanthronitrile compound M10 in the above-mentioned embodiment 11 is different from that in the embodiment 10 in that:

[0202] S5. The reactants are intermediate β2, phenothiazine and potassium tert-butoxide.

[0203] Example 12

[0204] This embodiment provides a phenanthronitrile compound M11, M11 has a molecular structure as shown in the above general formula (II), and the specific molecular structure is as follows:

[0205]

[0206] The preparation method of the phenanthrene nitrile compound M11 in the above-mentioned embodiment 12 is different from that in the embodiment 10 in that:

[0207] S5. The reactants are intermediate β2, 9,10-dihydro-9,9-dimethylacridine and potassium tert-butoxide.

[0208] Embodiment 13

[0209] This embodiment provides a phenanthronitrile compound M12, M12 has a molecular structure as shown in the above general formula (II), and the specific molecular structure is as follows:

[0210]

[0211] The method for preparing the phenanthrene nitrile compound M12 in Example 13 is different from that in Example 10 in that:

[0212] S5. The reactants are intermediate β2, carbazole and potassium tert-butoxide.

[0213] Embodiment 14

[0214] This embodiment provides a phenanthronitrile compound M13, M13 has a molecular structure as shown in the above general formula (II), and the specific molecular structure is as follows:

[0215]

[0216] The method for preparing the phenanthrene nitrile compound M13 in Example 14 is different from that in Example 1 in that:

[0217] S5. The reactants are intermediate β2, diphenylamine and potassium tert-butoxide.

[0218] Embodiment 15

[0219] This embodiment provides a phenanthronitrile compound M14, M14 has a molecular structure as shown in the above general formula (II), and the specific molecular structure is as follows:

[0220]

[0221] The preparation method of the phenanthrene nitrile compound M14 in the above-mentioned embodiment 15 is different from that in the embodiment 1 in that:

[0222] S5. The reactants are intermediate β2, diphenylamine and potassium tert-butoxide.

[0223] Performance Testing

[0224] The phenanthrene nitrile compounds M1, M2, M3, and M4 obtained in Examples 1 to 4 were characterized and their performances were tested.

[0225] The test method is as follows:

[0226] Compound structure detection: The samples were tested using a Bruker 400MHz superconducting nuclear magnetic resonance instrument, and the solvent was deuterated chloroform.

[0227] Mass spectrometry detection: M1, M2, M3, and M4 prepared in Example were dissolved in acetonitrile to prepare a solution with a concentration of 1 mg / mL, and the solution was subjected to mass spectrometry test using a liquid spectrometer LCMS-2020.

[0228] Ultraviolet absorption spectrum detection: Shimadzu UV-2700 ultraviolet visible spectrophotometer was used to test the samples, and the wavelength scanning range was 200-700 nm.

[0229] Emission spectrum detection: M1, M2, M3, and M4 prepared in Example 1 were dissolved in toluene solution to prepare 1×10 - 3 mol / L stock solution, when testing, dilute to 1×10 -5mol / L. The detection was carried out using a steady-state / transient fluorescence spectrometer (FLS980) under nitrogen protection, with an excitation wavelength of 320 nm and a test temperature of 300K.

[0230] Luminescence quantum yield (PLQY) test: using common CBP as the main material, first test the emission spectrum of the blank sample, i.e., the CBP film not doped with the phenanthronitrile compound prepared by the present invention; then test the emission spectrum of the CBP film doped with the phenanthronitrile compound prepared by the present invention under the condition that other conditions remain unchanged; finally, by comparing the emission spectra of the two, the number of emitted photons and the number of absorbed photons are obtained, and the ratio of the two is the PLQY.

[0231] The test results are as follows:

[0232] Table 1. Luminescence quantum yields PLQY of compounds M1 to M4 obtained in Examples 1 to 4 at different concentrations

[0233] Doping concentration 1% 3% 5% 7% 10% M1's PLQY 35% 34.5% 32.8% 30.9% 27.9% M2's PLQY 40.1% 39.5% 38.1% 37% 35% M3's PLQY 100% 100% 97.1% 95% 88% M4's PLQY 78% 75% 72.3% 69% 65%

[0234] Fig. 9 The M1, M2, M3, and M4 prepared in the examples are 1×10 -5 mol / L fluorescence emission spectrum in toluene. Fig. 9 It can be seen that the main emission peak position of M1 is 693nm, the emission peak of M2 is 636nm, the emission peak of M3 is 531nm, and M4 is 555nm. Wherein M1 is compared with M2, and the phenanthrene nucleus in the M1 molecule has one more cyano substituent, and the phenanthrene nucleus has a stronger electron-withdrawing ability, and the electrostatic interaction between DA is stronger, and electrons are more easily transferred between the two, so the singlet-triplet energy level difference of the molecule is reduced, and the luminescence wavelength is also red-shifted from 636nm of M2 to 693nm. Compared with M1, M3 and M4 use triphenylamine and spirofluorene acridine with weaker electron-donating ability to replace phenoxazine, so that the luminescence wavelength is blue-shifted from 693nm to 531nm and 555nm respectively. Therefore, the phenanthrene nitrile compound provided by the present invention can realize the regulation of the molecular luminescence wavelength by regulating the type of the electron donor group.

[0235] It can be seen from Table 1 that as the doping concentration increases, the luminescence quantum yield of the phenanthronitrile compounds provided by the present invention only decreases slightly. When the doping concentration increases from 1wt% to 10wt%, the luminescence quantum yield of M1 only decreases by 7.1%, that of M2 only decreases by 5.1%, that of M3 only decreases by 12%, and that of M4 only decreases by 13%. It can be seen that the concentration quenching phenomenon common in DA-type TADF molecules is well suppressed.

Claims

1. A phenanthronitrile compound, characterized in that Having a molecular structure as shown in formula (I) or (II): Wherein the two R groups are independently selected from -H, -CN or Any one of, and at least one R is -CN; D1, D2 are electron donor groups, each independently selected from the following structural formula: wherein R1 is selected from any one of -H and -t-Bu.

2. The phenanthronitrile compound according to claim 1, characterized in that The molecular structure is shown in one of the following:

3. A method for preparing the phenanthronitrile compound according to any one of claims 1 to 2, characterized in that: The preparation method of the compound of formula (I) comprises the following steps: S1. Using copper and cuprous iodide to catalyze the self-coupling of 2-bromo-4-fluorotoluene under nitrogen protection to obtain 5,5'-difluoro-2,2'-dimethyl-1,1'-biphenyl; S2. The 5,5'-difluoro-2,2'-dimethyl-1,1'-biphenyl prepared in S1 is mixed with bromosuccinimide and reacted to prepare 2,2'-bis(dibromomethyl)-5,5'-difluoro-1,1'-biphenyl; S3. Mix and react the 2,2'-bis(dibromomethyl)-5,5'-difluoro-1,1'-biphenyl obtained in S2 with potassium tert-butoxide to obtain intermediate α1 S4. Dissolve the intermediate α1 prepared in S3 and cuprous cyanide in N-methylpyrrolidone to prepare intermediate β1 under nitrogen protection. S5. The intermediate β1 prepared in S4 is dissolved together with the alkaline salt and the donor group in an organic solvent, and heated to obtain a phenanthronitrile compound having a molecular structure as shown in formula (I).

4. A method for preparing the phenanthronitrile compound according to any one of claims 1 to 2, characterized in that: The preparation method of the compound of formula (I) comprises the following steps: S1. Mixing 2-(4-bromophenyl)acetonitrile, iodine and a base, and reacting them to obtain 2,3-bis(4-bromophenyl)fumaronitrile; S2. The 2,3-bis(4-bromophenyl)fumaronitrile obtained in step S1 is mixed with iodine and reacted under light to obtain 3,6-dibromophenyl-9,10-dinitrile; S3. The 3,6-dibromophenyl-9,10-dinitrile, donor group, alkaline salt and phosphine palladium catalyst prepared in step S2 are mixed and heated to prepare a phenanthronitrile compound having a molecular structure as shown in formula (I).

5. A method for preparing the phenanthronitrile compound according to any one of claims 1 to 2, characterized in that: The preparation method of the compound of formula (II) comprises the following steps: S1. Using copper and cuprous iodide to catalyze the self-coupling of 1-bromo-4-fluoro-2-toluene under nitrogen protection to prepare 4,4'-difluoro-2,2'-dimethyl-1,1'-biphenyl; S2. The 4,4'-difluoro-2,2'-dimethyl-1,1'-biphenyl prepared in S1 is mixed with bromosuccinimide and reacted to prepare 2,2'-bis(dibromomethyl)-4,4'-difluoro-1,1'-biphenyl; S3. Mixing and reacting the 2,2'-bis(dibromomethyl)-4,4'-difluoro-1,1'-biphenyl obtained in S2 with potassium tert-butoxide to obtain a 2,7-substituted intermediate α2; S4. The intermediate α2 prepared in S3 and cuprous cyanide are dissolved in N-methylpyrrolidone to prepare a 2,7-substituted intermediate β2 under nitrogen protection; S5. The intermediate β2 prepared in S4 is dissolved together with the alkaline salt and the donor group in an organic solvent, and heated to prepare a phenanthronitrile compound having a molecular structure as shown in (II).

6. Use of the phenanthronitrile compound according to any one of claims 1 to 2 in an organic light-emitting device.

7. The use of the phenanthronitrile compound in an organic light-emitting device according to claim 6, characterized in that: The organic light-emitting device has one or more light-emitting layers, and the light-emitting layers contain at least one or more phenanthronitrile compounds according to any one of claims 1 to 2.

8. An organic light-emitting device, characterized in that: The light-emitting layer of the organic light-emitting device comprises one or more phenanthronitrile compounds according to any one of claims 1 to 2.

Citation Information

Patent Citations

  • Organic electroluminescent material and use thereof

    CN105131938A

  • Organic electroluminescent material and application thereof

    CN107652307A

  • TADF material and application in OLED (organic light emitting diode) device

    CN108191767A

  • Material for organic electroluminescence device and organic electroluminescence device using the same

    US20150171357A1

  • Organic electroluminescent element, light-emitting thin film, display device, and lighting device

    WO2016017514A1